1300 related articles for article (PubMed ID: 12709465)
61. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
[TBL] [Abstract][Full Text] [Related]
62. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Dahlöf B; Devereux RB; Kjeldsen SE; Julius S; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristiansson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H;
Lancet; 2002 Mar; 359(9311):995-1003. PubMed ID: 11937178
[TBL] [Abstract][Full Text] [Related]
63. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
64. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
[TBL] [Abstract][Full Text] [Related]
65. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Damian DJ; McNamee R; Carr M
BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
[TBL] [Abstract][Full Text] [Related]
66. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
[TBL] [Abstract][Full Text] [Related]
67. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; Neaton JD; Grimm RH; Hansson L; Lacourcière Y; Muller JE; Sleight P; Weber MA; White WB; Williams GH; Wittes J; Zanchetti A; Anders RJ;
J Hypertens; 2005 May; 23(5):1099-106. PubMed ID: 15834298
[TBL] [Abstract][Full Text] [Related]
68. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
Glasser SP; Frishman W; White WB; Stone P; Johnson MF
Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
[TBL] [Abstract][Full Text] [Related]
69. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
[TBL] [Abstract][Full Text] [Related]
70. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
Philipp T; Anlauf M; Distler A; Holzgreve H; Michaelis J; Wellek S
BMJ; 1997 Jul; 315(7101):154-9. PubMed ID: 9251545
[TBL] [Abstract][Full Text] [Related]
71. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).
Mancia G; Omboni S; Parati G;
J Hypertens; 2002 Mar; 20(3):545-53. PubMed ID: 11875324
[TBL] [Abstract][Full Text] [Related]
72. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
[TBL] [Abstract][Full Text] [Related]
73. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A;
J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
[TBL] [Abstract][Full Text] [Related]
74. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
[TBL] [Abstract][Full Text] [Related]
75. A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
Antonios TF; Cappuccio FP; Markandu ND; Sagnella GA; MacGregor GA
Hypertension; 1996 Jun; 27(6):1325-8. PubMed ID: 8641743
[TBL] [Abstract][Full Text] [Related]
76. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
[TBL] [Abstract][Full Text] [Related]
77. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
Cooper-DeHoff RM; Gong Y; Handberg EM; Bavry AA; Denardo SJ; Bakris GL; Pepine CJ
JAMA; 2010 Jul; 304(1):61-8. PubMed ID: 20606150
[TBL] [Abstract][Full Text] [Related]
78. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L; Lanke J; Lindholm LH; De Faire U; Dahlöf B; Karlberg BE;
J Hypertens; 2002 Jun; 20(6):1231-7. PubMed ID: 12023696
[TBL] [Abstract][Full Text] [Related]
79. A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients.
Svensson-Färbom P; Wahlstrand B; Almgren P; Dahlberg J; Fava C; Kjeldsen S; Hedner T; Melander O
J Hypertens; 2011 Feb; 29(2):388-95. PubMed ID: 21052022
[TBL] [Abstract][Full Text] [Related]
80. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
Schiffrin EL; Park JB; Pu Q
J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
